Newsroom

APRIL 26 2021 Fred Pennic What You Should Know: – Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. – Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized...

APRIL 26 2021 WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. Editor's Note: This article originally posted on Glytec's website. The funding will fuel Glytec’s mission of revolutionizing the role glycemic...

APRIL 27 2021 Mallory Hackett The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement. Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors. The company collected $9 million in debt financing from...

APRIL 26 2021 Sean Whooley Glytec announced today that it raised $21 million in financing to fund its glycemic management technology. Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a news release. The company said it plans to use...

APRIL 27 2021 Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included:$9m debt financing from SVB, and$12m equity investment led by Savitr Capital and other private investors. Led by Ed Furlong, President and Chief Executive Officer, Glytec is an insulin management software company that delivers...

MAY 9 2021 Omar Ford COVID-19 and digital health are two subjects that loomed largely in this year’s Medical Design Excellence Awards (MDEA) Program. The prestigious award program—recognizing cutting-edge achievements in medical product design since 1998— spans 11 categories and celebrates the Best in Show and MD+DI Readers' Choice. (For a complete list of finalists, please click here) With...

APRIL 26 2021 Christine Hall Glytec is developing software that aims to set the standard for insulin dosing and glycemic management in hospitals. On Monday, the company brought in a new round of $21 million in equity and debt financing. More than 34 million Americans today live with diabetes, while 88 million live with prediabetes and over one-third of all patients — regardless of a diabetes...

APRIL 26 2021 Steven Loeb The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don't are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven't invested in computerized protocols to deliver personalized dosing regimens,...

APRIL 26 2021 Steven Loeb The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don't are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven't invested in computerized protocols to deliver personalized dosing regimens, meaning...

APRIL 27 2021 Dennis Dailey Funding from Silicon Valley Bank and Savitr Capital Fuels Growth and Accelerates Innovation to Address Glycemic Management Challenges at Vast Majority of Hospitals Glytec, a provider of insulin management software across the continuum of care, announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding...